RESEARCH LABORATORY USE ONLY · NOT FOR HUMAN OR ANIMAL CONSUMPTION

fovea.bio

Scientific Literature Library

Reference literature & chemical specifications.

A neutral academic repository detailing the physical chemistry, molecular targets, and published preclinical literature for each reference material catalogued. Provided strictly for researcher reference and in-vitro study guidance.

Elamipretide (SS-31)

CAS: 736992-11-5
Formula: C32H49N9O5
MW: 639.80 g/mol
Target: Mitochondrial Cardiolipin / Inner Membrane
Sequence: D-Arg-Dmt-Lys-Phe-NH2 (Dmt: 2,6-dimethyltyrosine)

Biochemical Profile

A cell-permeable, aromatic-cationic tetrapeptide that selectively targets and binds cardiolipin on the inner mitochondrial membrane. Prevents cardiolipin peroxidation and maintains structural integrity of mitochondrial cristae under photo-oxidative stress.

Key Literature References

Preclinical Study2013

Mitochondria-targeted antioxidant peptide SS31 protects the retinas of diabetic rats

Current Molecular Medicine

Preclinical assessment showing SS-31 protects retinal cells by preserving mitochondrial membrane potential, reducing ROS, and preventing apoptosis.

DOI: 10.2174/15665240113139990049Source Link →
Biochemical Analysis2020

SS-31 interacts with cardiolipin to protect electron transport chain architecture

Journal of Biological Chemistry

Structural characterization of the electrostatic and hydrophobic forces driving the binding of SS-31 to negatively charged cardiolipin domains, optimizing ATP output.

DOI: 10.1074/jbc.RA120.012543Source Link →

Beta-Nicotinamide Adenine Dinucleotide (NAD⁺)

CAS: 53-84-9
Formula: C21H27N7O14P2
MW: 663.43 g/mol
Target: Sirtuins (SIRT1-7), PARP1, Complex I

Biochemical Profile

An essential coenzyme involved in cellular redox reactions and serves as a vital substrate for NAD⁺-consuming enzymes, including sirtuins and poly(ADP-ribose) polymerases (PARPs). Vital for sustaining metabolic flux in highly energy-dependent retinal ganglion axons.

Key Literature References

Preclinical Trial2017

Nicotinamide treatment robustly protects from inherited mouse glaucoma

eLife

Preclinical demonstration that age-dependent decline of NAD+ renders retinal ganglion cells vulnerable to intraocular pressure, and that nicotinamide prevents metabolic collapse and structural shearing.

DOI: 10.7554/eLife.26169Source Link →
Literature Review2024

Mitochondrial Resilience in Glaucoma: Targeting NAD+ Metabolism and Oxidative Stress in Retinal Ganglion Cell Degeneration

Diseases

Reviewing the metabolic collapse of optic nerve axons resulting from depletion of the localized NAD⁺ pool and the protective role of NAD+ precursors like nicotinamide riboside.

DOI: 10.3390/diseases14020056Source Link →

Epitalon (AEDG)

CAS: 307297-39-8
Formula: C14H22N4O9
MW: 390.35 g/mol
Target: hTERT Promoter / Telomerase Enzyme Complex
Sequence: L-Ala-L-Glu-L-Asp-Gly (AEDG)

Biochemical Profile

A synthetic tetrapeptide designed to model the biological activity of natural epithalamin. Investigated for its reported ability to interact with the promoter region of the hTERT gene, leading to telomerase activation and cellular senescence delay.

Key Literature References

In Vitro Study2003

Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells

Bulletin of Experimental Biology and Medicine

Quantifying the reactivation of hTERT expression and corresponding telomere structural lengthening in cultured fibroblasts exposed to synthetic AEDG.

DOI: 10.1023/a:1025493705728Source Link →
Literature Review2020

AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism

Molecules

Review of the peptide's epigenetic mechanisms and its ability to influence retinal neuronal differentiation and RPE function as a retinoprotector.

DOI: 10.3390/molecules25030609Source Link →

MOTS-c

CAS: 1627503-51-9
Formula: C101H163N33O25S2
MW: 2363.78 g/mol
Target: AMPK / Complex I / Metabolic Regulators
Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Ala-Leu-Lys-Arg-Asp-Gly-Arg-Gly-Val

Biochemical Profile

A 19-amino-acid peptide encoded by the mitochondrial 12S rRNA gene. Acts as an endocrine-like metabolic signal that translocates to the nucleus under metabolic stress, promoting glucose utilization, AMPK phosphorylation, and protecting against phototoxic metabolic collapse.

Key Literature References

Discovery Paper2015

Mitochondrial peptide MOTS-c regulates metabolic homeostasis via the AMPK pathway

Cell Metabolism

Identification of the physiological role of MOTS-c, its translocation to the nucleus, and its control over folate and metabolic pathways.

DOI: 10.1016/j.cmet.2015.01.012Source Link →
In Vitro Study2022

MOTS-c protects retinal pigment epithelial cells from oxidative stress-induced mitochondrial dysfunction

Free Radical Biology and Medicine

Preclinical measurements of cell viability, oxygen consumption rate (OCR), and mitochondrial ROS production in HEV-exposed RPE models treated with MOTS-c.

DOI: 10.1016/j.freeradbiomed.2022.04.015Source Link →

Pinealon (EDR)

CAS: 175175-23-2
Formula: C15H26N6O8
MW: 418.41 g/mol
Target: Neuronal Gene Expression / Caspase-3 / ROS Pathways
Sequence: L-Glu-L-Asp-L-Arg (EDR)

Biochemical Profile

A synthetic tripeptide derived from the active sequence of Cortexin (a cerebral cortex polypeptide complex). Investigated as a peptide bioregulator with reported neuroprotective mechanisms including reactive oxygen species suppression, anti-apoptotic caspase-3 modulation, and dendritic spine morphology restoration in preclinical hypoxia and neurodegeneration models.

Key Literature References

In Vitro Study2021

Short Peptides Stimulate Serotonin Expression in Cells of Brain Cortex

Bulletin of Experimental Biology and Medicine

Investigation of EDR peptide effects on serotonin expression and neuronal gene regulation in cortical cell cultures, demonstrating dose-dependent modulation of neurotransmitter synthesis pathways.

DOI: 10.1007/s10517-021-05069-0Source Link →
Preclinical Study2014

Tripeptide EDR (Pinealon): Neuroprotective Effects in Models of Hypoxia and Neurodegeneration

Advances in Gerontology

Preclinical assessment of EDR tripeptide neuroprotection under hypoxic conditions, demonstrating ROS reduction, caspase-3 modulation, and improved neuronal viability in oxidative-stress cell models.

DOI: 10.1134/S2079057014040079Source Link →

Academic Reference Terms

Summaries are extracted from published biochemical literature for descriptive purposes. The inclusion of literature reviews or molecular parameters does not constitute or imply a claim of physiological efficacy, benefit, or fitness for human use. These compounds are supplied strictly for laboratory research and in-vitro study.